Elon Musk’s Neuralink is preparing to scale up production of its brain-computer interface devices and implement fully automated surgical implantation in 2026, Musk announced on X Wednesday.
The cutting-edge implant is designed to assist individuals with severe neurological conditions, including spinal cord injuries.
Early recipients have used the device to play video games, browse the internet, post on social media, and control a laptop cursor entirely through thought.
Neuralink launched human trials in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected its application in 2022.
By September, 12 people worldwide with significant paralysis had received Neuralink implants, allowing them to manipulate both digital and physical tools using their neural signals.
The company also secured $650 million in a June funding round to accelerate development and production efforts.
